Primex Pharma is an international specialty pharmaceutical company that sources, markets, and distributes high‑quality anesthetic and pediatric sedation medicines, including a novel oral midazolam solution. By leveraging outsourced manufacturing with strict quality controls and a global regulatory and distribution network, it provides hospitals and anesthesiology departments rapid access to compliant, niche anesthetic therapies. The firm also offers partnership options such as licensing, distribution agreements, and M&A to expand product reach.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare providers often face limited access to specialized anesthetic and pediatric sedation medicines that meet stringent safety and efficacy standards, especially in diverse international markets. This scarcity can delay procedures, increase costs, and compromise patient outcomes in perioperative care.
Solution
Primex Pharma operates as an international, commercially focused specialty pharmaceutical company that sources, markets, and distributes high-quality anesthetic products, including a novel oral midazolam solution for pediatric sedation. By outsourcing manufacturing to vetted partners under strict quality controls, the company maintains financial flexibility while ensuring product consistency. Its global regulatory and distribution network enables rapid market entry and compliance across multiple regions. Primex also offers strategic partnership options such as licensing, distribution agreements, and M&A to expand product reach and address unmet clinical needs. This lean, de‑risked business model allows the firm to quickly acquire and commercialize niche anesthetic therapies, supporting better perioperative patient outcomes worldwide.
Target Audience
Primary customers are hospitals, anesthesiology departments, and pediatric surgical centers seeking reliable specialty anesthetic medicines, as well as pharmaceutical partners looking for licensing or distribution collaborations.
Features
- Portfolio of specialty anesthetic drugs (e.g., propofol formulations, oral midazolam solution) targeting perioperative and pediatric sedation needs
- Outsourced manufacturing with rigorous quality oversight to ensure compliance and cost efficiency
- In‑house global regulatory affairs expertise facilitating multi‑regional approvals and market entry
- Established international distribution channels and local marketing capabilities across Europe, Asia, and the Americas
- Flexible partnership models including licensing, distribution agreements, and acquisition opportunities
- Dedicated pharmacovigilance and medical affairs teams to monitor safety and support clinicians